Table 5.
Sensitivity and specificity of Egami, Sano, Kobayashi and Kawanet scores to predict unresponsiveness to intravenous immunoglobulin in our KD population and by ethnicity.
| Egami n = 320 patients | Sano n = 211 patients | Kobayashi cut-off ≥4 n = 334 patients | Kobayashi cut-off ≥5 n = 334 patients | Kawanet Cut-off ≥2 n = 415 patients | ||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Se (%) | Sp(%) | Se(%) | Sp(%) | Se(%) | Sp(%) | Se(%) | Sp(%) | Se(%) | Sp(%) | |
| Whole KD population | 51 | 71 | 14 | 86 | 61 | 68 | 43 | 83 | 77 | 60 |
| European Caucasians | 51 | 72 | 18 | 84 | 53 | 71 | 36 | 82 | 74 | 57 |
| Eastern Caucasian or North African/Middle Eastern patients | 33 | 76 | 0 | 89 | 71 | 68 | 57 | 93 | 80 | 65 |
| African or Afro-Caribbean patients | 71 | 82 | 20 | 91 | 88 | 69 | 63 | 85 | 88 | 56 |
Se: sensitivity; Sp: specificity.